Top

Published in:

Open Access 01-12-2024 | Deep Brain Stimulation | Study protocol

A multicenter double-blind randomized crossover study comparing the impact of dorsal subthalamic nucleus deep brain stimulation versus standard care on apathy in Parkinson’s disease: a study protocol

Authors: T. J. C. Zoon, G. van Rooijen, M. F. Contarino, S. van der Gaag, R. Zutt, J. T. van Asseldonk, P. van den Munckhof, P. R. Schuurman, D. A. J. P. Denys, R. M. A. de Bie

Published in: Trials | Issue 1/2024

Abstract

Background

Neuroimaging studies suggest an association between apathy after deep brain stimulation (DBS) and stimulation of the ventral part of the subthalamic nucleus (STN) due to the associative fibers connected to the non-motor limbic circuits that are involved in emotion regulation and motivation. We have previously described three patients with severe apathy that could be fully treated after switching stimulation from a ventral electrode contact point to a more dorsal contact point.

Objectives

To determine whether more dorsal stimulation of the STN decreases apathy compared to standard care in a multicenter randomized controlled trial with a crossover design.

Methods

We will include 26 patients with a Starkstein Apathy Scale (SAS) score of 14 or more after subthalamic nucleus (STN) deep brain stimulation (DBS) for refractory Parkinson’s disease. This is a multicenter trial conducted in two teaching hospitals and one university medical center in the Netherlands after at least 3 months of STN DBS. Our intervention will consist of 1 month of unilateral dorsal STN stimulation compared to treatment as usual. The primary outcome is a change in SAS score following 1 month of DBS on the original contact compared to the SAS score following 1 month of DBS on the more dorsal contact. Secondary outcomes are symptom changes on the Movement Disorders Society-Unified Parkinson’s Disease Rating Scale motor part III, Montgomery-Åsberg Depression Rating Scale, 39-item Parkinson’s disease questionnaire, Parkinson’s disease impulsive-compulsive disorders questionnaire, changes in levodopa-equivalent daily dosage, apathy rated by the caregiver, and burden and quality of life of the caregiver.

Trial registration

ClinicalTrials.gov NL8279. Registered on January 10, 2020.

Available only for authorised users

Odekerken VJ, van Laar T, Staal MJ, Mosch A, Hoffmann CF, Nijssen PC, et al. Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson’s disease (NSTAPS study): a randomised controlled trial. Lancet Neurol. 2013;12(1):37–44.PubMedCrossRef

Krack P, Batir A, Van Blercom N, Chabardes S, Fraix V, Ardouin C, et al. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson’s disease. N Engl J Med. 2003;349(20):1925–34.PubMedCrossRef

Lhommee E, Wojtecki L, Czernecki V, Witt K, Maier F, Tonder L, et al. Behavioural outcomes of subthalamic stimulation and medical therapy versus medical therapy alone for Parkinson’s disease with early motor complications (EARLYSTIM trial): secondary analysis of an open-label randomised trial. Lancet Neurol. 2018;17(3):223–31.PubMedCrossRef

Zoon TJC, van Rooijen G, Balm G, Bergfeld IO, Daams JG, Krack P, et al. Apathy induced by subthalamic nucleus deep brain stimulation in Parkinson’s disease: a meta-analysis. Mov Disord. 2021;36(2):317–26.PubMedCrossRef

Santangelo G, Trojano L, Barone P, Errico D, Grossi D, Vitale C. Apathy in Parkinson’s disease: diagnosis, neuropsychological correlates, pathophysiology and treatment. Behav Neurol. 2013;27(4):501–13.PubMedPubMedCentralCrossRef

Martinez-Fernandez R, Pelissier P, Quesada JL, Klinger H, Lhommee E, Schmitt E, et al. Postoperative apathy can neutralise benefits in quality of life after subthalamic stimulation for Parkinson’s disease. J Neurol Neurosurg Psychiatry. 2016;87(3):311–8.PubMedCrossRef

Ricciardi L, Morgante L, Epifanio A, Zibetti M, Lanotte M, Lopiano L, Morgante F. Stimulation of the subthalamic area modulating movement and behavior. Parkinsonism Relat Disord. 2014;20(11):1298–300.PubMedCrossRef

Crespo-Burillo JA, Rivero-Celada D, Saenz-de Cabezon A, Casado-Pellejero J, Alberdi-Vinas J, Alarcia-Alejos R. Deep brain stimulation for patients with Parkinson’s disease: effect on caregiver burden. Neurologia. 2018;33(3):154–9.PubMedCrossRef

Pagonabarraga J, Kulisevsky J, Strafella AP, Krack P. Apathy in Parkinson’s disease: clinical features, neural substrates, diagnosis, and treatment. Lancet Neurol. 2015;14(5):518–31.PubMedCrossRef

10.

Starkstein SE, Leentjens AF. The nosological position of apathy in clinical practice. J Neurol Neurosurg Psychiatry. 2008;79(10):1088–92.PubMedCrossRef

11.

Groenewegen HJ, Wright CI, Uylings HB. The anatomical relationships of the prefrontal cortex with limbic structures and the basal ganglia. J Psychopharmacol. 1997;11(2):99–106.PubMedCrossRef

12.

Mega MS, Cummings JL, Salloway S, Malloy P. The limbic system: an anatomic, phylogenetic, and clinical perspective. J Neuropsychiatry Clin Neurosci. 1997;9(3):315–30.PubMedCrossRef

13.

Thobois S, Ardouin C, Lhommee E, Klinger H, Lagrange C, Xie J, et al. Non-motor dopamine withdrawal syndrome after surgery for Parkinson’s disease: predictors and underlying mesolimbic denervation. Brain. 2010;133(Pt 4):1111–27.PubMedCrossRef

14.

Thobois S, Lhommee E, Klinger H, Ardouin C, Schmitt E, Bichon A, et al. Parkinsonian apathy responds to dopaminergic stimulation of D2/D3 receptors with piribedil. Brain. 2013;136(Pt 5):1568–77.PubMedCrossRef

15.

Brown RG, Pluck G. Negative symptoms: the ‘pathology’ of motivation and goal-directed behaviour. Trends Neurosci. 2000;23(9):412–7.PubMedCrossRef

16.

Stefurak T, Mikulis D, Mayberg H, Lang AE, Hevenor S, Pahapill P, et al. Deep brain stimulation for Parkinson’s disease dissociates mood and motor circuits: a functional MRI case study. Mov Disord. 2003;18(12):1508–16.PubMedCrossRef

17.

Higuchi MA, Tsuboi Y, Inoue T, Fukuyama K, Abe H, Baba Y, Yamada T. Predictors of the emergence of apathy after bilateral stimulation of the subthalamic nucleus in patients with Parkinson’s disease. Neuromodulation. 2015;18(2):113–7.PubMedCrossRef

18.

Zoon TJ, de Bie RM, Schuurman PR, van den Munckhof P, Denys D, Figee M. Resolution of apathy after dorsal instead of ventral subthalamic deep brain stimulation for Parkinson’s disease. J Neurol. 2019;266(5):1267–9.PubMedCrossRef

19.

Starkstein SE, Mayberg HS, Preziosi TJ, Andrezejewski P, Leiguarda R, Robinson RG. Reliability, validity, and clinical correlates of apathy in Parkinson’s disease. J Neuropsychiatry Clin Neurosci. 1992;4(2):134–9.PubMedCrossRef

20.

Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, et al. Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord. 2008;23(15):2129–70.PubMedCrossRef

21.

Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134:382–9.PubMedCrossRef

22.

Jenkinson C, Fitzpatrick R, Peto V, Greenhall R, Hyman N. The Parkinson’s disease questionnaire (PDQ-39): development and validation of a Parkinson’s disease summary index score. Age Ageing. 1997;26(5):353–7.PubMedCrossRef

23.

Weintraub D, Hoops S, Shea JA, Lyons KE, Pahwa R, Driver-Dunckley ED, et al. Validation of the questionnaire for impulsive-compulsive disorders in Parkinson’s disease. Mov Disord. 2009;24(10):1461–7.PubMedPubMedCentralCrossRef

24.

Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE. Systematic review of levodopa dose equivalency reporting in Parkinson’s disease. Mov Disord. 2010;25(15):2649–53.PubMedCrossRef

25.

Marin RS, Biedrzycki RC, Firinciogullari S. Reliability and validity of the Apathy Evaluation Scale. Psychiatry Res. 1991;38(2):143–62.PubMedCrossRef

26.

Ware JE Jr, Sherbourne CD. The MOS 36-Item Short-Form Health Survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30(6):473–83.PubMedCrossRef

27.

Odekerken VJ, Boel JA, Schmand BA, de Haan RJ, Figee M, van den Munckhof P, et al. GPi vs STN deep brain stimulation for Parkinson disease: three-year follow-up. Neurology. 2016;86(8):755–61.PubMedCrossRef

28.

Holewijn RA, Verbaan D, van den Munckhof PM, Bot M, Geurtsen GJ, Dijk JM, et al. General anesthesia vs local anesthesia in microelectrode recording-guided deep-brain stimulation for parkinson disease: the GALAXY randomized clinical trial. JAMA Neurol. 2021;78(10):1212–9.PubMedCrossRef

29.

Geraedts VJ, van Ham RAP, Marinus J, van Hilten JJ, Mosch A, Hoffmann CFE, et al. Intraoperative test stimulation of the subthalamic nucleus aids postoperative programming of chronic stimulation settings in Parkinson’s disease. Parkinsonism Relat Disord. 2019;65:62–6.PubMedCrossRef

30.

Czernecki V, Schupbach M, Yaici S, Levy R, Bardinet E, Yelnik J, et al. Apathy following subthalamic stimulation in Parkinson disease: a dopamine responsive symptom. Mov Disord. 2008;23(7):964–9.PubMedCrossRef

31.

Castor Electronic Data Capture Available at: https://castoredc.com. [press release]. 2019.

32.

Leentjens AF, Dujardin K, Marsh L, Martinez-Martin P, Richard IH, Starkstein SE, et al. Apathy and anhedonia rating scales in Parkinson’s disease: critique and recommendations. Mov Disord. 2008;23(14):2004–14.PubMedCrossRef

33.

Davidson J, Turnbull CD, Strickland R, Miller R, Graves K. The Montgomery-Asberg Depression Scale: reliability and validity. Acta Psychiatr Scand. 1986;73(5):544–8.PubMedCrossRef

34.

Tan LC, Luo N, Nazri M, Li SC, Thumboo J. Validity and reliability of the PDQ-39 and the PDQ-8 in English-speaking Parkinson’s disease patients in Singapore. Parkinsonism Relat Disord. 2004;10(8):493–9.PubMedCrossRef

35.

Probst CC, Winter LM, Moller B, Weber H, Weintraub D, Witt K, et al. Validation of the questionnaire for impulsive-compulsive disorders in Parkinson’s disease (QUIP) and the QUIP-rating scale in a German speaking sample. J Neurol. 2014;261(5):936–42.PubMedPubMedCentralCrossRef

36.

Brazier JE, Harper R, Jones NM, O’Cathain A, Thomas KJ, Usherwood T, Westlake L. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ. 1992;305(6846):160–4.PubMedPubMedCentralCrossRef

37.

Ishihara L, Brayne C. A systematic review of depression and mental illness preceding Parkinson’s disease. Acta Neurol Scand. 2006;113(4):211–20.PubMedCrossRef

38.

Schuepbach WM, Rau J, Knudsen K, Volkmann J, Krack P, Timmermann L, et al. Neurostimulation for Parkinson’s disease with early motor complications. N Engl J Med. 2013;368(7):610–22.PubMedCrossRef

39.

Czernecki V, Pillon B, Houeto JL, Welter ML, Mesnage V, Agid Y, Dubois B. Does bilateral stimulation of the subthalamic nucleus aggravate apathy in Parkinson’s disease? J Neurol Neurosurg Psychiatry. 2005;76(6):775–9.PubMedPubMedCentralCrossRef

40.

Funkiewiez A, Ardouin C, Krack P, Fraix V, Van Blercom N, Xie J, et al. Acute psychotropic effects of bilateral subthalamic nucleus stimulation and levodopa in Parkinson’s disease. Mov Disord. 2003;18(5):524–30.PubMedCrossRef

41.

Fabbri M, Coelho M, Abreu D, Guedes LC, Rosa MM, Godinho C, et al. Dysphagia predicts poor outcome in late-stage Parkinson’s disease. Parkinsonism Relat Disord. 2019;64:73–81.PubMedCrossRef

42.

Grover S, Somaiya M, Kumar S, Avasthi A. Psychiatric aspects of ’s disease. J Neurosci Rural Pract. 2015;6(1):65–76.PubMedPubMedCentralCrossRef

43.

Drapier D, Drapier S, Sauleau P, Haegelen C, Raoul S, Biseul I, et al. Does subthalamic nucleus stimulation induce apathy in Parkinson’s disease? J Neurol. 2006;253(8):1083–91.PubMedCrossRef

Title: A multicenter double-blind randomized crossover study comparing the impact of dorsal subthalamic nucleus deep brain stimulation versus standard care on apathy in Parkinson’s disease: a study protocol
Authors: T. J. C. Zoon
G. van Rooijen
M. F. Contarino
S. van der Gaag
R. Zutt
J. T. van Asseldonk
P. van den Munckhof
P. R. Schuurman
D. A. J. P. Denys
R. M. A. de Bie
Publication date: 01-12-2024
Publisher: BioMed Central
Keywords: Deep Brain Stimulation
Parkinson's Disease
Published in: Trials / Issue 1/2024
Electronic ISSN: 1745-6215
DOI: https://doi.org/10.1186/s13063-024-07938-9

Keynote webinar | Spotlight on medication adherence

Springer Medicine

A multicenter double-blind randomized crossover study comparing the impact of dorsal subthalamic nucleus deep brain stimulation versus standard care on apathy in Parkinson’s disease: a study protocol

Abstract

Background

Objectives

Methods

Trial registration

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Objectives

Methods

Trial registration

Please log in to get access to this content

Other articles of this Issue 1/2024

Coordination of COVID-19 platform trials in Europe

Implementation of supplemental physiotherapy following hip fracture surgery: a protocol for the process evaluation of a randomised controlled trial

Dreaming during gastrointestinal endoscopy under propofol, ciprofol, or remimazolam anesthesia: study protocol for a parallel-design double-blind, single-center trial

A randomised controlled trial to compare the efficacy, safety, and tolerability of low dose, short course primaquine in adults with uncomplicated P. vivax malaria in two hospitals in India

Efficacy of a virtual reality-based cognitive interactive training program for children with traumatic brain injuries: study protocol for a parallel-group randomized controlled trial

Autogenic splenic implantation versus splenectomy in patients undergoing distal pancreatectomy for benign or low-grade malignant lesions of the distal pancreas: study protocol for a multicentre, open-label, randomized controlled trial (RESTORE)